{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "BLKB",
  "name": "Blackbaud, Inc.",
  "url": "https://orbyd.app/dossiers/BLKB/",
  "json_url": "https://orbyd.app/dossiers/BLKB.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Busted vertical-SaaS name re-rating on cash return: the 2026-07-29 Q2 print showed +3.0% organic and an affirmed FY26 guide with upper-half commentary, against ~$850M of remaining buyback authorization and an 8.16 forward P/E. The move is already extended — RSI(14) 80.1 at the 2026-08-07 close of $45.87 — with no scheduled catalyst until an unannounced Q3 print.",
  "invalidation_trigger": "A weekly close below $40 retraces the post-Q2 re-rating leg in full; a trim to the FY26 revenue guide of $1.173–$1.179B or organic growth back under 3.0% at the Q3 print (~2026-10-28, est.) would be the fundamental confirmation.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "ai-enterprise-software"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Blackbaud pays no dividend; all shareholder return runs through the repurchase program, so capital-return risk and buyback pace are the same variable.",
    "A limited-duration shareholder rights plan was adopted in 2024 after the Clearlake proposal was rejected; its expiry is not confirmed in publicly reviewed sources.",
    "Revenue was 98.2% recurring in Q2 FY26, so quarterly revenue surprises are small; the real variance shows up in bookings and renewal commentary on the call.",
    "The 2020 security incident produced regulatory settlements disclosed in prior filings; current 10-K risk factors should be checked for residual claims."
  ],
  "body_markdown": "## Current Thesis\n\nBlackbaud is no longer being priced as a growth-software name. The pipeline's adjusted bars put the 52-week high at $70.17; stockanalysis.com shows a 52-week low of $25.58 as of 2026-08-07. What is being re-underwritten now is a cash-return and share-count-shrinkage story, and the 2026-07-29 Q2 print supplied the evidence for it: GAAP revenue $290.6M (+3.0%), non-GAAP organic revenue +3.0%, recurring revenue $285.3M (+3.3%) at 98.2% of total, adjusted EPS $1.33 versus a $1.28 consensus, and FY2026 guidance affirmed at $1.173–$1.179B revenue and $5.15–$5.25 adjusted EPS — with management stating it expects to finish in the upper half of the revenue, adjusted EBITDA, non-GAAP EPS and free-cash-flow ranges, and EPS and FCF at the high end.\n\nThe capital-return leg is the load-bearing part. As of 2026-06-30 roughly $850M remained under the repurchase program that was expanded and reauthorized in December 2025; the company had repurchased just over 6% of shares year-to-date and has reduced shares outstanding by approximately 15% since Q4 2023. Shares outstanding stood at 44.72M against a $2.05B market cap and an 8.16 forward P/E (stockanalysis.com, 2026-08-07).\n\nThe complication is the tape. The 2026-08-07 close of $45.87 carried RSI(14) at 80.1 and a 22.3% three-month gain while still sitting 34.6% below the 52-week high. Nothing on the company's own calendar resolves anything before the Q3 print, which had not been scheduled as of 2026-08-08.\n\n## Bull Case\n\n- **Q2 FY26 (2026-07-29):** GAAP revenue $290.6M, +3.0%; non-GAAP organic revenue +3.0%; GAAP recurring revenue $285.3M, +3.3%, equal to 98.2% of total revenue. Adjusted EPS $1.33 against $1.28 consensus.\n- **Guide affirmed with a positive skew (2026-07-29):** FY2026 revenue $1.173–$1.179B (consensus $1.176B) and adjusted EPS $5.15–$5.25 (consensus $5.19), plus explicit commentary that the company expects the upper half of its ranges, with EPS and free cash flow at the high end.\n- **The issuer is the marginal buyer:** ~$850M remaining under the repurchase authorization at 2026-06-30, just over 6% of shares retired year-to-date, ~15% fewer shares outstanding than Q4 2023. Set that $850M figure beside the $2.05B market cap at the 2026-08-07 close.\n- **Multiple:** forward P/E 8.16, trailing P/E 14.27, TTM EPS $3.22, TTM net income $150.68M on $1.15B TTM revenue (stockanalysis.com, 2026-08-07). Consensus analyst target $53.40 versus the $45.87 close.\n- **Revenue quality:** at 98.2% recurring in Q2, the free cash flow funding the buyback is subscription-derived rather than order-book dependent.\n- **Sponsor precedent (historical, not live):** Blackbaud confirmed receipt of an unsolicited, non-binding all-cash proposal from Clearlake Capital at $80.00 per share on 2024-04-15, which the board reviewed and rejected; a limited-duration shareholder rights plan followed in 2024. That is a two-year-old data point about how a financial buyer once priced the asset, and no current bid is in evidence.\n\n## Bear Case\n\n- **The top line missed:** revenue $290.597M against $292.303M consensus on 2026-07-29. The beat was on the EPS line, which a shrinking denominator flatters.\n- **One quarter is not a re-acceleration:** TTM revenue growth was 0.7% as of 2026-08-07 (stockanalysis.com) against the 3.0% Q2 organic print. A single quarter establishes nothing about the trend.\n- **The sell-side has not converted.** Stifel maintained Hold and cut its target to $30 on 2026-07-10. Evercore ISI maintained In-Line and raised its target to $48 on 2026-07-30. The 2026-08-07 close of $45.87 already trades well above one published target and within a few dollars of the other; the recent rating actions were target adjustments without a rating change.\n- **Overhead supply:** the name is 34.6% below the $70.17 adjusted 52-week high. Every level between the current price and that high was distribution for holders who bought higher in the prior twelve months.\n- **Buyback dependency cuts both ways:** with 44.72M shares outstanding, EPS growth leans on repurchase pace. A free-cash-flow shortfall would hit both the numerator and the pace of denominator reduction in the same quarter.\n- **Leverage unquantified here:** the sources reviewed for this note do not give a current net-debt figure. Any assessment of how much of the $850M authorization is fundable from cash flow versus balance sheet requires the Q2 10-Q.\n\n## Setup & Price Structure\n\n- **Price basis:** $45.87 close, 2026-08-07. RSI(14) 80.1. Three-month return +22.3%. Distance from the $70.17 52-week high: -34.6%. 52-week low $25.58 (stockanalysis.com, 2026-08-07).\n- **Life-cycle: ACCELERATING.** What dates it: the 2026-07-29 Q2 beat-and-affirm, the 2026-07-30 Evercore target raise to $48, and an RSI(14) of 80.1 at the 2026-08-07 close after a 22.3% three-month advance. The qualification matters — the participation evidence is thin. The label rests mostly on the price-and-headline leg, not on demonstrated flow expansion.\n- **Crowding observables, stated as observables:** RSI(14) 80.1 is at the extreme end of its range; price is far extended above the 52-week low; the company itself remains a programmatic buyer under the $850M residual authorization; no insider transactions were verified in the sources reviewed for this note; the next company-scheduled catalyst is roughly eleven weeks out. There is no imminent earnings date compressing the move, which removes a common near-term crowding trigger and also removes the event that would refresh the story.\n- **Structure:** the advance is a retracement of a deep drawdown, so the relevant reference is the pre-print consolidation the stock left behind on 2026-07-29 rather than a base breakout. The $40 area sits below that post-print range; a weekly close under it would mean the July print's re-rating has been fully given back.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-08 to 2026-09-07:** no company-scheduled event confirmed as of 2026-08-08. The window is genuinely empty; the tape carries the story unaided.\n- **~2026-10-28 (est.):** Q3 FY26 results. Not announced as of 2026-08-08. Q2 was reported Wednesday 2026-07-29 before the open, which is the basis for the estimate.\n- **~2026-12 (est.):** the repurchase program was expanded, replenished and reauthorized in December 2025; a further board action on the authorization would be the next scheduled read on capital-return intent. Unconfirmed.\n- **Unscheduled:** any Schedule 13D/A amendment from a large holder. Nothing dated is pending.\n\n## What Would Change Our Mind\n\nThe structure that breaks first is the guide, not the chart. The entire July advance sits on an affirmed FY26 range of $1.173–$1.179B revenue and $5.15–$5.25 adjusted EPS plus management's upper-half commentary. If the Q3 print (~2026-10-28, est.) trims that revenue range, or organic growth returns below the 3.0% posted in Q2, the cash-return case loses the growth floor that makes an 8.16 forward P/E defensible rather than a value trap.\n\nSecond, the buyback is the mechanism. If the next 10-Q shows the repurchase pace decelerating materially against the just-over-6% year-to-date reduction, or the $850M residual authorization draws down more slowly, the largest identified buyer of the stock has stepped back.\n\nThird, on price: a weekly close below $40 retraces the post-Q2 leg in full and puts the name back inside the range it occupied when Stifel published a $30 target on 2026-07-10.\n\nThe reverse also applies. A rating upgrade — Stifel off Hold, or Evercore off In-Line — rather than another target tweak would mark the coverage catching up to the price, and would argue the re-rating has room the current In-Line/Hold consensus does not reflect. A 13D amendment from a large holder would reintroduce the strategic-value question that the 2024-04-15 $80.00 proposal put on the table and that has been dormant since.\n\n## Correlation Notes\n\n- **Not an AI-capex derivative.** Blackbaud's revenue is nonprofit, faith, K-12/higher-education and social-impact vertical software. Its 2026 product messaging includes an AI-assisted connected-campus partnership with Student First; the announcement date for that partnership was not confirmed in the sources reviewed here, so it is noted without a date rather than counted as a catalyst. Correlation to semiconductor and hyperscaler AI beta should be treated as low.\n- **Small-cap software value complex.** The move since late July is characteristic of busted-multiple software repricing on capital return. Read moves in that cohort — not in high-multiple growth software — as the relevant read-across.\n- **End-market sensitivity is fiscal and donative, not cyclical-industrial.** Nonprofit fundraising volumes and education budgets drive renewals and payment volumes; the 98.2% recurring mix means these show up in bookings and renewal commentary on the call before they appear in the revenue line.\n- **Rate and credit sensitivity is unquantified in this note.** A repurchase-led EPS algorithm is sensitive to funding conditions, but the reviewed sources do not give a current net-debt figure, so no magnitude is asserted.",
  "first_seen": "2026-07-28",
  "last_analyzed": "2026-08-09T08:10:07+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "theme_discovery",
  "license": "Content © orbyd. Cite the canonical URL."
}